Preclinical assessment of a novel human antibody VH domain targeting mesothelin as an antibody-drug conjugate

Mesothelin (MSLN) has been a validated tumor-associated antigen target for several solid tumors for over a decade, making it an attractive option for therapeutic interventions. Novel antibodies with high affinity and better therapeutic properties are needed. In the current study, we have isolated an...

Полное описание

Библиографические подробности

Главные авторы:	Zehua Sun, Xiaojie Chu, Cynthia Adams, Tatiana V. Ilina, Michel Guerrero, Guowu Lin, Chuan Chen, Dontcho Jelev, Rieko Ishima, Wei Li, John W. Mellors, Guillermo Calero, Dimiter S. Dimitrov
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Elsevier 2023-12-01
Серии:	Molecular Therapy: Oncolytics
Предметы:	VH domain library ADC MSLN in vivo distribution structure
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S2372770523000694
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!